Liver transplant-associated graft-versus-host disease

Transplantation

Volumn 75, Issue 1, 2003, Pages 118-126

  Smith, Douglas M ^a   Agura, Edward ^a   Netto, George ^a   Collins, Robert ^b   Levy, Marlon ^a   Goldstein, Robert ^a   Christensen, Laura ^a   Baker, Judy ^a   Altrabulsi, Basel ^a   Osowski, Lori ^a,c   McCormack, Jeff ^a,d   Fichtel, Lisa ^a,e   Dawson, D Brian ^b   Domiati Saad, Rana ^b   Stone, Marvin ^a   Klintmalm, Goran ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c AMERICAN RED CROSS   (United States)

^d Digiscript   (United States)

^e TEXAS ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHIMERA; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCYTOPENIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037439755     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200301150-00022     Document Type: Article

References (42)

1. Collins RH, Cooper B, Nikaein A, et al. Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 1992; 116(5): 391.
2. Collins RH, Anastasi JM, Terstappen LWM, et al. Donor-derived longterm multilineage hematopoiesis in a liver transplant recipient. N Engl J Med 1993; 328: 762.
3. Collins RH, Sackler M, Pitcher CJ, et al. Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation. Exp Hematol 1997; 25: 147.
4. Roberts JP, Ascher NL, Lake J, et al. Graft vs. host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14(2): 274.
5. Sanchez-Izquierdo JA, Lumbreras C, Colina F, et al. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996; 43: 1057.
6. Burt M, Jazwinska E, Lynch S, et al. Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient. Liver Transpl Surg 1996; 2(5): 391.
7. Marubayashi S, Matsuzaka C, Takeda A, et al. Fatal generalized acute graft-versus-host disease in a liver transplant recipient. Transplantation 1990; 50(4): 709.
8. Burdick JF, Vogelsang GB, Smith WJ, et al. Severe graft-versus-host disease in a liver transplant recipient. N Engl J Med 1988; 318(11): 689.
9. Mazzaferro V, Andreola S, Regalia E, et al. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. Transplantation 1993; 55(2): 423.
10. Rosen CB, Ng CS, Moore SB, et al. Clinical and pathological features of graft-versus-host disease after liver transplantation: a case report and review of the literature. Clin Transplant 1993; 7: 52.
11. DePaoli AM. Graft-versus-host disease and liver transplantation. Ann Intern Med 1992; 117: 170.
12. Redondo P, España A, Herrero JI, et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993; 29(2): 314.
13. Bhaduri BR, Tan KC, Humphreys S, et al. Graft-versus-host disease after orthotopic liver transplantation in a child. Transplant Proc 1990; 22(5): 2378.
14. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991; 4: 67.
15. Joysey VC, Wood H, Ramsbottom S, et al. Lymphocyte chimaerism after organ transplantation. Transpl Proc 1992; 24(6): 2519.
16. Comenzo RL, Malachowski ME, Rohrer RJ, et al. Anomalous ABO pheno-type in a child after an ABO-incompatible liver transplantation. N Engl J Med 1992; 326(13): 867.
17. Pageaux GP, Perrigault PF, Fabre JM, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995; 9: 65.
18. Neumann UP, Kaisers U, Langrehr JM, et al. Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994; 26(6): 3616.
19. Connors J, Drolet B, Walsh J, et al. Morbilliform eruption in a liver transplantation patient. Arch Dermatol 1996; 132: 1161.
20. Cattral MS, Langnas AN, Wisecarver JL, et al. Survival of graft-versus-host disease in a liver transplant recipient. Transplantation 1994; 57(8): 1271.
21. Reference deleted.
22. Merle C, Blanc D, Flesch M, et al. Tableau de necrolyse epidermique apres allogreffe hepatique. Ann Dermatol Venereol 1990; 117: 635.
23. Joseph JM, Mosimann F, Tiercy JM, et al. PCR confirmation of microchimerism and diagnosis of graft versus host disease after liver transplantation. Transplant Int 1999; 12: 468.
24. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000; 6(2): 180.
25. Hanaway MJ, Buell JF, Musat AI, et al. Graft-versus-host disease in solid organ transplant. Graft 2001; 4(3): 205.
26. Kiuchi T, Harada H, Matsukawa H, et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transplant Int 1998; 11(Suppl 1): S383.
27. Whitington PF, Rubin CM, Alonso EM, et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation 1996; 62(10): 1516.
28. Aziz H TP, Lendoire J, Bianco G, et al. Successful treatment of graft-vs-host disease after a second liver transplant. Transplant Proc 1998; 30: 2891.
29. Paizis GTB, Kyle P, Angus PW, et al. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood. Aust N Z J Med 1998; 28: 830.
30. Lehner FBT, Sybrecht L, Luck R, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002; 73(2): 307.
31. Nuckols JD, Rasheed BK, McGlennen RC, et al. Evaluation of automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit. Am J Clin Pathol 2000; 113(1): 135.
32. Norris S, Doherty DG, Collins C, et al. Killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cells. Hum Immunol 1999; 60: 20.
33. Petz LD, Calhoun L, Yam P, et al. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors. Transfusion 1993; 33(9): 742.
34. Spector D. Transfusion-associated graft-versus-host disease: an overview and two case reports. Oncol Nurs Forum 1995; 22(1): 97.
35. Brubaker DB. Immunopathogenic mechanisms of posttransfusion graft-vs-host disease. Proc Soc Exp Biol Med 1993; 202(2): 122.
36. Ohto H, Anderson KC. Posttransfusion graft-versus-host disease in Japanese newborns. Transfusion 1996; 36: 117.
37. Schlitt HJ, Kanehiro H, Raddatz G, et al. Persistence of donor lymphocytes in liver allograft patients. Transplantation 1993; 56(4): 1001.
38. Billingham RE. The biology of graft-versus-host reactions. Harvey Lect 1966; 62: 21.
39. Simonsen M. Graft-versus-host reaction: their natural history and applicability as tools in research. Blood Bank Weekly 1962; 6: 349.
40. Reyes J, Todo S, Green M, et al. Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997; 11(5 Pt 1): 345.
41. Petersdorf EW, Gooley TA, Anasetti C, et al. optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92(10): 3515.
42. Shaffer D, Maki T, DeMichele SJ, et al. Studies in small bowel transplantation. Prevention of graft-versus-host disease with preservation of allograft function by donor pretreatment with antilymphocyte serum. Transplantation 1988; 45(2): 262.